In addition to improving therapeutic efficacy by co-encapsulating multiple drugs, another challenge that CSHNs can overcome is enhanced uptake by cells. As has been well documented in the literature, the plasma membranes surrounding cells and organelles reduce the permeability of molecules and drug delivery systems. In an attempt to bring these systems into cells, cell-penetrating peptides have been proposed. Briefly, these peptides function like a